Schmidt A, von Teutul A, Buddecke E
Hoppe Seylers Z Physiol Chem. 1984 Apr;365(4):445-56. doi: 10.1515/bchm2.1984.365.1.445.
Arterial smooth muscle cells cultured from rat aorta were labelled with sodium [35S]-sulfate in combination with either [3H]glucosamine or [3H]mannose. The newly synthesized hyaluronate and sulfated proteoglycans obtained from the growth medium (M-PG) and extracted from the cell layer (C-PG) with 4M guanidinium chloride in the presence of proteinase inhibitors were purified by sequential fractionation on Sepharose 4B CL, equilibrium density gradient centrifugation and ion exchange chromatography under dissociative conditions. Gel filtration of M-PG resulted in the separation of free hyaluronate and two size classes of [35S]-proteoglycan populations eluted at Kav 0.15 (fraction M-A) and 0.48 (fraction M-B). On further fractionation M-A dissociated into hyaluronate (Mr 1.6 X 10(6)) and a proteoglycan monomer (M-PG A, Mr 180 000), which contained chondroitin 4-sulfate (Mr 21 000) as the main glycosaminoglycan moiety. The proteoglycan isolated from M-B (M-PG B) was identified as a proteoglycan monomer (Mr 200 000) containing mainly chondroitin sulfate/dermatan sulfate hybrid side chains (Mr 34 000). [3H]Mannose labelling and binding to ConA Sepharose of both M-PG A and B indicated the presence of oligosaccharides of the glycoprotein type. An analogous fractionation of proteoglycans associated with the cell layer yielded two hyaluronate-proteoglycan complexes (C- PreA and C-A). The proteoglycan monomers of these complexes (C-PG PreA and C-PG A) had Mr values of 420 000 and 130 000. A non-complexed proteoglycan monomer C-PG B (Mr 90 000) was also found. All cell layer bound proteoglycans had glycosaminoglycan side chains with Mr approximately 36 000 but the predominant glycosaminoglycan component was either heparan sulfate, chondroitin sulfate or dermatan sulfate. All cell layer bound proteoglycans contained [3H]mannose radioactivity, about 15% of which was bound to ConA Sepharose.
用[35S] - 硫酸钠与[3H] - 葡糖胺或[3H] - 甘露糖联合标记从大鼠主动脉培养的动脉平滑肌细胞。从生长培养基中获得的新合成的透明质酸和硫酸化蛋白聚糖(M - PG)以及在蛋白酶抑制剂存在下用4M氯化胍从细胞层中提取的(C - PG),通过在琼脂糖4B CL上连续分级分离、平衡密度梯度离心和在解离条件下的离子交换色谱进行纯化。M - PG的凝胶过滤导致游离透明质酸和两种大小类别的[35S] - 蛋白聚糖群体的分离,它们在Kav 0.15(组分M - A)和0.48(组分M - B)处洗脱。进一步分级分离时,M - A解离为透明质酸(Mr 1.6×10(6))和一种蛋白聚糖单体(M - PG A,Mr 180 000),其含有硫酸软骨素4 - 硫酸酯(Mr 21 000)作为主要的糖胺聚糖部分。从M - B分离的蛋白聚糖(M - PG B)被鉴定为一种蛋白聚糖单体(Mr 200 000),主要含有硫酸软骨素/硫酸皮肤素杂合侧链(Mr 34 000)。M - PG A和B的[3H] - 甘露糖标记以及与伴刀豆球蛋白A琼脂糖的结合表明存在糖蛋白类型的寡糖。对与细胞层相关的蛋白聚糖进行类似的分级分离产生了两种透明质酸 - 蛋白聚糖复合物(C - PreA和C - A)。这些复合物的蛋白聚糖单体(C - PG PreA和C - PG A)的Mr值分别为420 000和130 000。还发现了一种非复合的蛋白聚糖单体C - PG B(Mr 90 000)。所有细胞层结合的蛋白聚糖都具有Mr约为36 000的糖胺聚糖侧链,但主要的糖胺聚糖成分是硫酸乙酰肝素、硫酸软骨素或硫酸皮肤素。所有细胞层结合的蛋白聚糖都含有[3H] - 甘露糖放射性,其中约15%与伴刀豆球蛋白A琼脂糖结合。